DEERFIELD MANAGEMENT CO
Q1 2014 13F-HR Holdings
Net value change ($000)
+519,068
(26.9%)
New positions
47
Sold out positions
28
Turnover %
51.5%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| LH | 69,699 | NEW |
| Dicerna Pharmaceuticals Inc | 68,607 | NEW |
| AUSPEX PHARMACEUTICALS INC | 61,181 | NEW |
| INTERMUNE INC | 53,015 | NEW |
| ABBV | 52,685 | NEW |
| FLAMEL TECHNOLOGIES SA | 35,580 | 102.0% |
| MCK | 28,781 | NEW |
| Medtronic PLC | 28,555 | NEW |
| *SYNAGEVA BIOPHARMA CORP | 26,358 | NEW |
| DGX | 25,502 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| HUM | -42,802 | -100.0% |
| GMED | -34,194 | -100.0% |
| CUBIST PHARMACEUTICALS INC | -26,603 | -100.0% |
| SNDA | -26,013 | -76.5% |
| XOMA | -25,620 | -100.0% |
| AETNA INC NEW | -22,429 | -100.0% |
| MOMENTA PHARMACEUTICALS INC | -20,096 | -100.0% |
| MYLAN INC | -15,724 | -94.8% |
| Horizon Therapeutics PLC Com | -15,527 | -43.9% |
| AUXILIUM PHARMACEUTICALS | -15,507 | -18.2% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
271,125
(11.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|